Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

WARRANTS (Details Narrative) - USD ($)					3 Months Ended
WARRANTS (Details Narrative) - USD ($)	Mar. 06, 2024	Jun. 01, 2023	Oct. 16, 2020	Jul. 28, 2020	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jan. 26, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number					432,919
Debt face amount					$ 12,972,769		$ 16,303,738
Share-Based Payment Arrangement, Tranche One [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Debt face amount				$ 20,000,000
CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares								33,334
Exercise price of warrants								$ 396
Investment Agreement [Member] \| CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares					50,207
Exercise price of warrants					$ 283.81
Weighted average remaining life of warrants					1 year 4 months 6 days
Warrant expire date					Jan. 26, 2025
Fair value of warrants issued					$ 6,215,225
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised	142,857	194,444		2,873
Exercise price of warrants				$ 208.8
Loan Agreement [Member] \| K2 Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised				2,873
Warrants outstanding to purchase of common stock shares				2,873
Exercise price of warrants				$ 208.8
Warrant expire date				Jul. 28, 2030
Fair value of warrants issued				$ 472,409
Professional Services Agreement [Member] \| Warrants [Member] \| Investor Relations Service Provider [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares			14,000
Exercise price of warrants			$ 32.1
Warrant expire date			Nov. 03, 2025
Fair value of warrants issued			$ 334,740
Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised					0	0